No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria

Parasitology Research

Volumn 100, Issue 3, 2007, Pages 487-493

  Mayengue, Pembe Issamou ^a,b   Kalmbach, Yvonne ^b   Issifou, Saadou ^a   Kremsner, Peter G ^a,b   Ntoumi, Francine ^a,b  

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE RESISTANCE TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HUMAN; MALARIA; MALE; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

ANIMALS; CHILD; CHILD, PRESCHOOL; FEMALE; GABON; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POINT MUTATION; PREVALENCE; PROTOZOAN PROTEINS; VARIATION (GENETICS);

PLASMODIUM FALCIPARUM;

EID: 33845765162     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-006-0287-8     Document Type: Article

References (46)

1. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D (2001) High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J Infect Dis 183:1535-1538
2. Basco LK, Ringwald P (1998) Molecular epidemiology of malaria in Yaoudé, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum. Am J Trop Med Hyg 59:577-581
3. Basco LK, Ringwald P (2002) Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohol's and artemisinin derivatives. Am J Trop Med Hyg 66:667-671
4. Basco LK, Le Bras J, Rhoades Z, Wilson CM (1995) Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol Biochem Parasitol 74:157-166
5. Binder RK, Borrmann S, Adegnika AA, Missinou MA, Kremsner PG, Kun JF (2002) Polymorphisms in the parasite genes for pfcrt and pfmdr1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambarene, Gabon. Parasitol Res 88:475-476
6. Borrmann S, Binder RK, Adegnika AA, Missinou MA, Issifou S, Ramharter M, Wernsdorfer WH, Kremsner PG (2002) Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. Trans R Soc Trop Med Hyg 96:660-663
7. Contamin H, Fandeur T, Bonnefoy S, Skouri F, Ntoumi F, Mercereau-Puijalon O (1995) PCR typing of field isolates of Plasmodium falciparum. J Clin Microbiol 33:944-951
8. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, DiourteY, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D (2001) A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344:257-263
9. Djimde AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV (2003) Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 69:558-563
10. Duraisingh MT, Drakeley CJ, Muller O, Bailey R, Snounou G, Targett GA, Greenwood BM, Warhurst DC (1997) Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114:205-211
11. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC (2000) The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 108:13-23
12. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ,Wootton JC, Roepe PD, Wellems TE (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6:861-871
13. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF (1990) Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255-258
14. Giha HA, Elbashir MI, A-Elbasit IE, A-Elgadir TME, Elgazali GE, Mackinnon MJ, Babiker HA (2006) Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. Acta Trop 97:181-187
15. Greenwood B, Mutabingwa T (2002) Malaria in 2002. Nature 415:670-672
16. Grobusch MP, Adagu IS, Kremsner PG, Warhurst DC (1998) Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon. Parasitology 116:211-217
17. Konate L, Zwetyenga J, Rogier C, Bischoff E, Fontenille D, Tall A, Spiegel A, Trape JF, Mercereau-Puijalon O (1999) Variation of Plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions. Trans R Soc Trop Med Hyg 93:21-28
18. Kun JF, Schmidt-Ott RJ, Lehman LG, Lell B, Luckner D, Greve B, Matousek P, Kremsner PG (1998) Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Trans R Soc Tropical Med Hyg 92:110-114
19. Kremsner PG, Winkler S, Brandts C, Graninger W, Bienzle U (1993) Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg 49:650-654
20. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W (1994) Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 169:467-470
21. Kremsner PG, Radloff P, Metzger W, Wildling E, Mordmüller B, Philipps J, Jenne L, Nkeyi M, Prada J, Bienzle U, Graninger W (1995) Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother 39:1603-1605
22. Krogstad DJ, Gluzman IY, Kyle DE, Oduola AM, Martin SK, Milhous WK, Schlesinger PH (1987) Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238:1283-1285
23. Lines JD, Wilkes TJ, Lyimo EO (1991) Human malaria infectiousness measured by age-specific sporozoite rates in Anopheles gambiae in Tanzania. Parasitology 102:167-177
24. Mawili-Mboumba DP, Kun JF, Lell B, Kremsner PG, Ntoumi F (2002) Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients. Antimicrob Agents Chemother 46:166-170
25. Mayor AG, Gomez-Olive X, Aponte JJ, Casimiro S, Mabunda S, Dgedge M, Barreto A, Alonso PL (2001) Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. J Infect Dis 183:1413-1416
26. Meerman L, Ord R, Bousema JT, van Niekerk M, Osman E, Hallett R, Pinder M, Walraven G, Sutherland CJ (2005) Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J Infect Dis 192:1651-1657
27. Nagesha HS, Din-Syafruddin, Casey GJ, Susanti AI, Fryauff DJ, Reeder JC, Cowman AF (2001) Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with invivo drug resistance in west Papua, Indonesia. Trans R Soc Trop Med Hyg 95:43-49
28. Ntoumi F, Ngoundou-Landji J, Lekoulou F, Luty A, Deloron P, Ringwald P (2000) Site-based study on polymorphism of Plasmodium falciparum MSP-1 and MSP-2 genes in isolates from two villages in Central Africa. Parassitologia 42:197-203
29. Omar SA, Adagu IS, Gump DW, Ndaru NP, Warhurst DC (2001) Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area. Ann Trop Med Parasitol 95:661-669
30. Planche T, Krishna S, Kombila M, Engel K, Faucher JF, Ngou-Milama E, Kremsner PG (2001) Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 65:599-602
31. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S (2004) Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447
32. Ranjit MR, Das A, Chhotray GP, Das BP, Das BN, Acharya AS (2004) The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection. Trop Med Int Health 9:857-861
33. Reed MB, Saliba KS, Caruana SR, Kirk K, Cowman AF (2000) Pdh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909
34. Robert F, Ntoumi F, Angel G, Candito D, Rogier C, Fandeur T, Sarthou JL, Mercereau-Puijalon O (1996) Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal. Trans R Soc Trop Med Hyg 90:704-711
35. Schmidt-Ott R, Luckner D, Lehman LG, Lell B, Matousek P, Greve B, Kremsner PG (1997) Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon. Trans R Soc Trop Med Hyg 91:578-579
36. Sidhu ABS, Valderramos SG, Fidock DA (2005) Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum Mol Microbiol 57:913-926
37. Sylla EH, Kun JF, Kremsner PG (2000) Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. Trans R Soc Trop Med Hyg 94:652-656
38. Thomas SM, Ndir O, Dieng T, Mboup S, Wypij D, Maguire JH, Wirth DF (2002) In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. Am J Trop Med Hyg 66:474-480
39. Trape JF, Pison G, Preziosi MP, Enel C, Desgrees du Lou A, Delaunay V, Samb B, Lagarde E, Molez JF, Simondon F (1998) Impact of chloroquine resistance on malaria mortality. C R Acad Sci III 321:689-697
40. Uhlemann AC, Ramharter M, Lell B, Kremsner PG, Krishna S (2005) Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis 192:1830-1835
41. Warhurst DC (2001) A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344:299-302
42. Wellems TE, Panton LJ, Gluzman LY, do Rosario VE, Gwadz RW, Walker-Jonah A, Krogstad DJ (1990) Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345:253-255
43. Wernsdorfer WH, Payne D (1991) The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 50:95-121
44. Wilson CM, Volkman SK, Thaithong S, Martin RK, Kyle DE, Milhous WK, Wirth DF (1993) Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 57:151-160
45. Winkler S, Brandts C, Wensdorfer WH, Graninger W, Bienzle U, Kremsner PG (1994) Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. Trop Med Parasitol 45:214-218
46. Zalis MG, Pang L, Silveira MS, Milhous WK, Wirth DF (1998) Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am J Trop Med Hyg 58:630-637